Thomas F. Isett - 08 Sep 2022 Form 4 Insider Report for iBio, Inc. (IBIO)

Role
CEO and Executive Chairman, Director
Signature
/s/Thomas F. Isett
Issuer symbol
IBIO
Transactions as of
08 Sep 2022
Net transactions value
$0
Form type
4
Filing time
12 Sep 2022, 16:02:00 UTC
Previous filing
27 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IBIO Stock Option (right to buy) Award $0 +2,000,000 $0.000000 2,000,000 08 Sep 2022 Common Stock 2,000,000 $0.2740 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest ratably in equal monthly instalments over a 36-month period beginning on the date of the grant (September 8, 2022), subject to the conditions of the iBio, Inc. 2020 Omnibus Incentive Compensation Plan, as amended, and the related stock option grant agreement.